This content is machine translated Medication against Covid-19 Therapy arsenal is constantly expanding The monoclonal antibodies casirivimab/imdevimab and sotrovimab received Swissmedic approval last December and this January, respectively. Another promising drug for the treatment of Covid 19 patients is expected to be launched…
